# Filing Detail

Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-26-051962
Filing Date
2026-04-30
Accepted
2026-04-30 06:00:29
Documents
21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFM14A | tm2613157-1_defm14a.htm | DEFM14A | 6985326
2 | GRAPHIC | lg_barinthus-4clr.jpg | GRAPHIC | 11240
3 | GRAPHIC | fc_celiacdisease-4c.jpg | GRAPHIC | 57531
4 | GRAPHIC | fc_figure02-4clr.jpg | GRAPHIC | 54077
5 | GRAPHIC | fc_figure03-4clr.jpg | GRAPHIC | 49067
6 | GRAPHIC | tb_balomenib-4c.jpg | GRAPHIC | 33729
7 | GRAPHIC | fc_figure05-4clr.jpg | GRAPHIC | 58950
8 | GRAPHIC | fc_figure06-4clr.jpg | GRAPHIC | 52007
9 | GRAPHIC | fc_figure07-4clr.jpg | GRAPHIC | 35309
10 | GRAPHIC | fc_figure08-4clr.jpg | GRAPHIC | 123088
11 | GRAPHIC | fc_figure09-4clr.jpg | GRAPHIC | 77644
12 | GRAPHIC | fc_figure10-4clr.jpg | GRAPHIC | 72828
13 | GRAPHIC | fc_figure11-4clr.jpg | GRAPHIC | 74260
14 | GRAPHIC | bc_figure12-4clr.jpg | GRAPHIC | 55010
15 | GRAPHIC | bc_figure13-4clr.jpg | GRAPHIC | 38262
16 | GRAPHIC | px_26beaconpx2pg01.jpg | GRAPHIC | 349286
17 | GRAPHIC | px_26beaconpx2pg02.jpg | GRAPHIC | 196751
18 | GRAPHIC | px_26beaconpx2pg03.jpg | GRAPHIC | 280474
19 | GRAPHIC | px_26beaconpx2pg04.jpg | GRAPHIC | 169642
20 | GRAPHIC | px_26beaconpx1pg01.jpg | GRAPHIC | 306491
21 | GRAPHIC | px_26beaconpx1pg02.jpg | GRAPHIC | 177286
| Complete submission text file | 0001104659-26-051962.txt |  | 10053185

Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-40367 | Film No.: 26919646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)